Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Oncotype DX Stories

2012-08-27 06:23:10

CLEVELAND, Aug. 27, 2012 /PRNewswire/ -- Lack of sleep is linked to more aggressive breast cancers, according to new findings published in the August issue of Breast Cancer Research and Treatment by physician-scientists from University Hospitals Case Medical Center's Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University. Led by Cheryl Thompson, PhD, the study is the first-of-its-kind to show an association between insufficient sleep and biologically...

2012-08-21 23:38:28

Editorial states that data has not led to reduction in clinical use of radiotherapy in older women A Rhode Island Hospital radiation oncologist says in a new editorial that research exploring the impact of radiotherapy in older women with low risk of breast cancer recurrence has little effect on actual clinical decisions. The editorial written by David E. Wazer, M.D., chief of the department of radiation oncology, is published in the current issue of the Journal of Clinical Oncology....

2012-08-09 02:29:58

IRVINE, Calif. and AMSTERDAM, Aug. 9, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced that Stefan Gluck, MD, PhD, will lead the company's Medical Advisory Board. As Chairman, Dr. Gluck is assembling a panel of leading medical oncologists, surgeons, scientists and pathologists to play a key role in advising Agendia on the clinical application of its extensive product pipeline, including its Symphony(TM)...

2012-08-08 10:25:16

REDWOOD CITY, Calif., Aug. 8, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2012. Total revenue increased to $57.6 million in the second quarter of 2012, compared with $50.8 million in 2011, an increase of 13 percent. Product revenue was $57.2 million in the second quarter of 2012, compared with $50.5 million for the same period in 2011, an increase of 13 percent. Net...

2012-08-07 02:29:15

REDWOOD CITY, Calif., Aug. 7, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Company will present at the 32(nd) Annual Canaccord Genuity Growth Conference in Boston on Tuesday, August 14, 2012 at 2:00 p.m. Eastern Time (ET). To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health's website at http://investor.genomichealth.com. Please connect to the website at least 15...

2012-08-01 10:26:52

REDWOOD CITY, Calif., Aug. 1, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, August 8 at 4:30 p.m. Eastern Time to discuss its second quarter 2012 financial results. The call and webcast will follow the release of the second quarter financial results after market close. Conference Call Details To access the live conference call on August 8 at 4:30 p.m. Eastern Time via phone, please dial...

2012-07-25 02:27:31

REDWOOD CITY, Calif., July 25, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the peer-reviewed journal PLoS ONE published positive results from its groundbreaking clinical outcomes study for biomarker discovery applying Next Generation Sequencing (NGS) for whole transcriptome profiling of archival formalin-fixed paraffin embedded (FFPE) tumor specimens. Results demonstrated that Genomic Health's proprietary whole transcriptome RNA-Seq technology successfully...

2012-06-11 21:47:03

A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn't effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. The study by lead author Justin Balko, Pharm.D., Ph.D., was published online June 10, 2012 in Nature Medicine in advance of print publication. Balko is a postdoctoral fellow in the laboratory of Carlos L....

2012-06-04 02:24:51

ANN ARBOR, Mich., June 4, 2012 /PRNewswire/ -- Everist Genomics, a rapidly growing personalized medicine company, today announced the publication of positive results from an international validation study which demonstrated that the OncoDefender-CRC colorectal cancer test result is a significant independent predictor of recurrence in node-negative, invasive colorectal cancer (CRC) patients. The study, originally presented, in part, at the 2011 American Society of Clinical Oncology (ASCO)...

2012-06-01 10:22:20

REDWOOD CITY, Calif., June 1, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of 18 studies being presented at the American Society for Clinical Oncology(®) (ASCO(®)) Annual Meeting taking place June 1-5 in Chicago, Illinois. New data includes validation of the Oncotype DX® colon cancer test in both stage II and stage III disease, the company's first prostate needle biopsy development study, and further evidence of the clinical value of the...